Serina Therapeutics, Inc. Increase (Decrease) in Accounts and Other Receivables
Serina Therapeutics, Inc. (SER) reported Increase (Decrease) in Accounts and Other Receivables of $53.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2024-03-22
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2023-12-31 was -$10.00K, a 433.33% decline year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2023-09-30 was $61.00K.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2023-06-30 was -$1.00K, a 108.33% decline year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for the quarter ending 2023-03-31 was $3.00K.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for fiscal 2023 was $53.00K.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for fiscal 2022 was -$21.00K.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for fiscal 2021 was -$128.00K, a 526.67% decline from fiscal 2020.
- Serina Therapeutics, Inc. increase (decrease) in accounts and other receivables for fiscal 2020 was $30.00K, a 87.07% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 3 month as first filed | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 6 month as first filed | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 9 month as first filed | Increase (Decrease) in Accounts and Other Receivables 12 month | Increase (Decrease) in Accounts and Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $51.00K derived: sum of 2 quarters · filed 2024-03-22 | $50.00K derived: sum of 3 quarters · filed 2024-03-22 | $53.00K 10-K · filed 2024-03-22 | ||||
| 2023-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $60.00K derived: sum of 2 quarters · filed 2023-11-14 | $63.00K 10-Q · filed 2023-11-14 | $66.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.00K 10-Q · filed 2023-08-14 | $5.00K derived: sum of 3 quarters · filed 2024-03-22 | -$6.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-03-31 | $3.00K 10-Q · filed 2023-05-12 | $6.00K derived: sum of 2 quarters · filed 2024-03-22 | -$5.00K derived: sum of 3 quarters · filed 2024-03-22 | $7.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$8.00K derived: sum of 2 quarters · filed 2024-03-22 | $4.00K derived: sum of 3 quarters · filed 2024-03-22 | -$21.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.00K derived: sum of 2 quarters · filed 2023-11-14 | -$24.00K 10-Q · filed 2023-11-14 | -$23.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$13.00K 10-Q · filed 2023-08-14 | -$12.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$25.00K 10-Q · filed 2023-05-12 | -$24.00K derived: sum of 2 quarters · filed 2023-05-12 | -$11.00K derived: sum of 3 quarters · filed 2023-05-12 | -$48.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $14.00K derived: sum of 2 quarters · filed 2023-03-31 | -$23.00K derived: sum of 3 quarters · filed 2023-03-31 | -$128.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$24.00K derived: sum of 2 quarters · filed 2022-11-10 | -$129.00K 10-Q · filed 2022-11-10 | -$47.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$142.00K 10-Q · filed 2022-08-12 | -$60.00K derived: sum of 3 quarters · filed 2022-08-12 | -$30.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$105.00K 10-Q · filed 2022-05-13 | -$23.00K derived: sum of 2 quarters · filed 2022-05-13 | $7.00K derived: sum of 3 quarters · filed 2022-05-13 | -$64.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $112.00K derived: sum of 2 quarters · filed 2022-03-29 | $41.00K derived: sum of 3 quarters · filed 2022-03-29 | $30.00K 10-K · filed 2022-03-29 | -$10.00K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$41.00K derived: sum of 2 quarters · filed 2021-11-12 | -$52.00K 10-Q · filed 2021-11-12 | -$94.00K 10-Q · filed 2020-11-16 | $77.00K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$82.00K 10-Q · filed 2021-08-13 | -$103.00K 10-Q · filed 2020-08-14 | $47.00K derived: sum of 3 quarters · filed 2021-08-13 | $73.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | -$11.00K 10-Q · filed 2021-05-17 | $28.00K 10-Q · filed 2020-05-14 | $118.00K derived: sum of 2 quarters · filed 2021-05-17 | $144.00K derived: sum of 3 quarters · filed 2021-05-17 | $146.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $155.00K derived: sum of 2 quarters · filed 2021-03-31 | $157.00K derived: sum of 3 quarters · filed 2021-03-31 | $232.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $28.00K derived: sum of 2 quarters · filed 2020-11-16 | $103.00K 10-Q · filed 2020-11-16 | $43.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $77.00K 10-Q · filed 2020-08-14 | $17.00K derived: sum of 3 quarters · filed 2020-08-14 | $84.00K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $75.00K 10-Q · filed 2020-05-14 | $15.00K derived: sum of 2 quarters · filed 2020-05-14 | $82.00K derived: sum of 3 quarters · filed 2020-05-14 | $152.00K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$60.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $7.00K derived: sum of 2 quarters · filed 2020-03-31 | $77.00K derived: sum of 3 quarters · filed 2020-03-31 | $24.00K 10-K/A · filed 2020-03-31 | ||||
| 2018-09-30 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $137.00K derived: sum of 2 quarters · filed 2019-11-14 | $84.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $17.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | -$53.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | -$322.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |